The Expression of SR Calcium Transport ATPase and the Na+/Ca2+Exchanger are Antithetically Regulated During Mouse Cardiac Development and in Hypo/hyperthyroidism
The mouse has been used extensively for generating transgenic animal models to study cardiovascular disease. Recently, a number of transgenic mouse models have been created to investigate the importance of sarcoplasmic reticulum (SR) Ca2+transport proteins in cardiac pathophysiology. However, the ex...
Gespeichert in:
Veröffentlicht in: | Journal of molecular and cellular cardiology 2000-03, Vol.32 (3), p.453-464 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The mouse has been used extensively for generating transgenic animal models to study cardiovascular disease. Recently, a number of transgenic mouse models have been created to investigate the importance of sarcoplasmic reticulum (SR) Ca2+transport proteins in cardiac pathophysiology. However, the expression and regulation of cardiac SR Ca2+ATPase and other Ca2+transport proteins have not been studied in detail in the mouse. In this study, we used multiplex RNase mapping analysis to determine SERCA2, phospholamban (PLB), and Na+/Ca2+-exchanger (NCX-1) gene expression throughout mouse heart development and in hypo/hyperthyroid animals. Our results demonstrate that the expression of SERCA2 and PLB mRNA increase eight-fold from fetal to adult stages, indicating that SR function increases with heart development. In contrast, the expression of the Na+/Ca2+-exchanger gene is two-fold higher in fetal heart compared to adult. Our study also makes the important observation that in hypothyroidic hearts the NCX-1 mRNA and protein levels were upregulated, whereas the SERCA2 mRNA/protein levels were downregulated. In hyperthyroidic hearts, however, an opposite response was identified. These findings are important and point out that the expression of NCX-1 is regulated antithetically to that of SERCA2 during heart development and in response to alterations in thyroid hormone levels. |
---|---|
ISSN: | 0022-2828 1095-8584 |
DOI: | 10.1006/jmcc.1999.1095 |